ASD - Press release from Seaside Therapeutics

[Marco]

To be presented at the International Meeting for Autism Research (IMFAR) 2013 Conference in Spain today.

Results of a Phase 2b trial of Arbaclofen (modified form of the Gaba B agonist Baclofen) for the treatment of autism spectrum.

Fairly short and self-explanatory :

http://www.fiercebiotech.com/press-...results-phase-2b-clinical-trial-arbaclofen-au

 

[Marco]

For anyone interested - this interesting thread was started by someone (High Function ASD) claiming to be involved in the Arbaclofen trial :

"I can say without a shadow of a doubt that the tablets work. Recently I went to a concert and ‘moshed’ with the rest of general admission. Scores of people pressing against me, all shouting in unison, the heat wave from the pyrotechnics, the stench of so many people breathing and sweating, getting bruises practically everywhere, and I loved every minute of it. I did not feel anxious or worried in this situation in anyway and was able to enjoy the concert to the fullest.

Contrast this with me being completely unable to go to a grocery store without entering Fight or Flight before the medication, and I feel that my life is flat out better because of this study. I still have some anxiety and fear in completely safe situations if it involves an ever changing environment, enough stimuli, and people. If fifteen milligrams three times per day makes me feel so much better, I am curious what a higher dosage might mean. I would love to be able to see."

http://www.wrongplanet.net/postt189567.html